Organon (OGN) EBT (2020 - 2026)
Organon (OGN) posted quarterly EBT of $183.0 million for Q2 2026, down 20.09% year-over-year from $229.0 million in Q2 2025, and down 14.08% on a QoQ basis from $213.0 million in Q1 2026.
Organon (OGN) EBT (2020 - 2026) Analysis & Trends
Organon has reported EBT for 7 years, with the latest figure at $183.0 million in Q2 2026.
- EBT for Q2 2026 came in at $183.0 million, down 20.09% year-over-year; the trailing twelve-month figure through Jun 2026 was $491.0 million (down 26.28% YoY), and the FY2025 annual result was $425.0 million, down 47.34% from the prior year.
- EBT slipped to $183.0 million in Q2 2026, from $213.0 million in the prior quarter.
- Over five years, EBT peaked at $562.0 million in Q4 2022 and troughed at -$148.0 million in Q4 2025.
- A 5-year average of $215.2 million and a median of $232.0 million in 2023 frame the typical range for EBT.
- The widest annual swing landed in 2024, when EBT jumped 158.75%; it then tumbled 214.73% in 2025.
- A 5-year view of EBT shows it stood at $562.0 million in 2022, then sank by 81.49% to $104.0 million in 2023, then gained by 24.04% to $129.0 million in 2024, then tumbled by 214.73% to -$148.0 million in 2025, then surged by 223.65% to $183.0 million in 2026.
- Per Business Quant data, the three most recent EBT figures were $183.0 million in Q2 2026, $213.0 million in Q1 2026, and -$148.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 2.80 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 2.77 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -10.25 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -653.00 Mn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 474.95 Mn |
| 10 | Organon | 3.61 Bn | 2.47 Bn | 847.00 Mn | 183.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 183.00 Mn |
| Mar 31, 2026 | 213.00 Mn |
| Dec 31, 2025 | -148.00 Mn |
| Sep 30, 2025 | 243.00 Mn |
| Jun 30, 2025 | 229.00 Mn |
| Mar 31, 2025 | 101.00 Mn |
| Dec 31, 2024 | 129.00 Mn |
| Sep 30, 2024 | 207.00 Mn |
| Jun 30, 2024 | 235.00 Mn |
| Mar 31, 2024 | 236.00 Mn |
| Dec 31, 2023 | 104.00 Mn |
| Sep 30, 2023 | 80.00 Mn |
| Jun 30, 2023 | 254.00 Mn |
| Mar 31, 2023 | 235.00 Mn |
| Dec 31, 2022 | 562.00 Mn |
| Sep 30, 2022 | 282.00 Mn |
| Jun 30, 2022 | 287.00 Mn |
| Mar 31, 2022 | 442.00 Mn |
| Dec 31, 2021 | 236.00 Mn |
| Sep 30, 2021 | 389.00 Mn |